Hematološke i biokemijske promjene u serumu nazimica pokusno invadiranih protozoonom Trypanosoma brucei

The aim of this experiment was to study the hematological and serum biochemical changes in domestic cross breed female gilts infected with Trypanosoma brucei parasites. Twelve gilts were purchased from piggeries in Zaria Nigeria and housed in clean, fl y proof pens in two groups of six infected and six controls. The gilts in the infected group were inoculated with approximately 1.8 × 106 Trypanosoma brucei parasites. All the inoculated gilts developed clinical trypanosomosis after a prepatent period of three (3) days. Significant differences (P<0.05) were observed in the mean values of Packed Cell Volume (PCV), total white blood cells and differential leukocytes count, serum proteins, aspartate amino transferase, creatine kinase, potassium, inorganic phosphates and calcium between the infected gilts and the controls. The implication of these findings in the pathology of trypanosomosis in this species is discussed.Cilj je bio istražiti hematološke i biokemijske promjene u serumu križanih nazimica invadiranih nametnikom Trypanosoma brucei. U istraživanje je bilo uključeno 12 nazimica nabavljenih na svinjogojstvima u Zariji u Nigeriji. Nazimice su bile podijeljene u pokusnu i kontrolnu skupinu te smještene u nastambe potpuno zaštićene od krilatih kukaca. U pokusnoj skupini bile su invadirane s približno 1,8 ×106 parazita Trypanosoma brucei. U svih invadiranih nazimica očitovali su se klinički znakovi tripanosomoze nakon prepatentnog perioda od tri dana. Značajne razlike (P<0,05) bile su primijećene u srednjim vrijednostima hematokrita, leukocita, diferencijalne krvne slike, serumskih proteina, aspartat aminotransferaze, kreatin kinaze, kalija, anorganskih fosfata i kalcija. U radu je raspravljeno značenje tih nalaza u patologiji tripanosomoze u svinja

Measuring the health-related Sustainable Development Goals in 188 countries : a baseline analysis from the Global Burden of Disease Study 2015

Background In September, 2015, the UN General Assembly established the Sustainable Development Goals (SDGs). The SDGs specify 17 universal goals, 169 targets, and 230 indicators leading up to 2030. We provide an analysis of 33 health-related SDG indicators based on the Global Burden of Diseases, Injuries, and Risk Factors Study 2015 (GBD 2015). Methods We applied statistical methods to systematically compiled data to estimate the performance of 33 health-related SDG indicators for 188 countries from 1990 to 2015. We rescaled each indicator on a scale from 0 (worst observed value between 1990 and 2015) to 100 (best observed). Indices representing all 33 health-related SDG indicators (health-related SDG index), health-related SDG indicators included in the Millennium Development Goals (MDG index), and health-related indicators not included in the MDGs (non-MDG index) were computed as the geometric mean of the rescaled indicators by SDG target. We used spline regressions to examine the relations between the Socio-demographic Index (SDI, a summary measure based on average income per person, educational attainment, and total fertility rate) and each of the health-related SDG indicators and indices. Findings In 2015, the median health-related SDG index was 59.3 (95% uncertainty interval 56.8-61.8) and varied widely by country, ranging from 85.5 (84.2-86.5) in Iceland to 20.4 (15.4-24.9) in Central African Republic. SDI was a good predictor of the health-related SDG index (r(2) = 0.88) and the MDG index (r(2) = 0.2), whereas the non-MDG index had a weaker relation with SDI (r(2) = 0.79). Between 2000 and 2015, the health-related SDG index improved by a median of 7.9 (IQR 5.0-10.4), and gains on the MDG index (a median change of 10.0 [6.7-13.1]) exceeded that of the non-MDG index (a median change of 5.5 [2.1-8.9]). Since 2000, pronounced progress occurred for indicators such as met need with modern contraception, under-5 mortality, and neonatal mortality, as well as the indicator for universal health coverage tracer interventions. Moderate improvements were found for indicators such as HIV and tuberculosis incidence, minimal changes for hepatitis B incidence took place, and childhood overweight considerably worsened. Interpretation GBD provides an independent, comparable avenue for monitoring progress towards the health-related SDGs. Our analysis not only highlights the importance of income, education, and fertility as drivers of health improvement but also emphasises that investments in these areas alone will not be sufficient. Although considerable progress on the health-related MDG indicators has been made, these gains will need to be sustained and, in many cases, accelerated to achieve the ambitious SDG targets. The minimal improvement in or worsening of health-related indicators beyond the MDGs highlight the need for additional resources to effectively address the expanded scope of the health-related SDGs.Peer reviewe

Definition, Assessment, Health Consequences and Management of Equine Obesity: A Review

Obesity is a state of abnormal or excessive fat accumulation. Obesity in horses increases the risk of developing a variety of health issues such as: insulin dysregulation (ID), reduced athleticism, colic, abnormal reproductive performance, laminitis, endotoxaemia, diabetes mellitus, hyperlipaemia, impaired thermoregulation, pituitary pars intermedia dysfunction, and osteochondrosis. Obesity is a significant health and welfare issue in horses that may go unreported or unnoticed due to a caregiver’s (owner) neglect. Weight gain occurs when a horse’s energy consumption exceeds his or her physical energy needs. Obesity is best assessed via necropsy or upon in vivo assessment with deuterium oxide administration, although this is not feasible in a clinical environment. In practice, obesity is assessed by: body condition scoring, cresty neck scoring, ultrasono graphic assessment, morphometric measurements, or biochemical indicators in the blood. Dietary and exercise programs are the primary means of controlling equine obesity. Pharmacologic assistance (levothyroxine sodium and metformin hydrochloride), being a secondary approach, may be effective in some cases. Management involves a long-term plan that requires the horse’s caregiver’s effort and discipline, as well as the support and supervision of their veterinarian. This paper outlines the assessment, health consequences, and management of equine obesity